These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 27416665
1. [Risk factors of ISUP Modified Gleason score upgrading after radical prostatectomy]. Li XD, Qu GY, Xu N, Xue XY, Wei Y, Zheng QS, Li JF, Cai H, Lin YZ. Zhonghua Nan Ke Xue; 2016 May; 22(5):415-9. PubMed ID: 27416665 [Abstract] [Full Text] [Related]
4. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O. Urol Oncol; 2011 May; 29(5):508-14. PubMed ID: 19837614 [Abstract] [Full Text] [Related]
5. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy]. Zuo Q, Zhang F, Huang Y, Ma LL, Lu M, Lu J. Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug 18; 48(4):603-606. PubMed ID: 29263497 [Abstract] [Full Text] [Related]
8. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. J Urol; 2002 Jul 18; 168(1):110-5. PubMed ID: 12050502 [Abstract] [Full Text] [Related]
10. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis. Ellis CL, Partin AW, Han M, Epstein JI. J Urol; 2013 Dec 18; 190(6):2068-73. PubMed ID: 23727307 [Abstract] [Full Text] [Related]
11. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis. Herlemann A, Buchner A, Kretschmer A, Apfelbeck M, Stief CG, Gratzke C, Tritschler S. World J Urol; 2017 Oct 18; 35(10):1517-1524. PubMed ID: 28493044 [Abstract] [Full Text] [Related]
12. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer. Sfoungaristos S, Perimenis P. Prague Med Rep; 2011 Oct 18; 112(4):263-71. PubMed ID: 22142521 [Abstract] [Full Text] [Related]
13. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer. Vellekoop A, Loeb S, Folkvaljon Y, Stattin P. J Urol; 2014 Feb 18; 191(2):350-7. PubMed ID: 24071481 [Abstract] [Full Text] [Related]
14. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis. Berg KD, Thomsen FB, Nerstrøm C, Røder MA, Iversen P, Toft BG, Vainer B, Brasso K. BJU Int; 2016 Jun 18; 117(6):883-9. PubMed ID: 26823232 [Abstract] [Full Text] [Related]
15. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy. Takeshima Y, Yamada Y, Teshima T, Fujimura T, Kakutani S, Hakozaki Y, Kimura N, Akiyama Y, Sato Y, Kawai T, Yamada D, Kume H. BMC Cancer; 2021 May 04; 21(1):501. PubMed ID: 33947348 [Abstract] [Full Text] [Related]
16. Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy. Miyake H, Muramaki M, Furukawa J, Tanaka H, Inoue TA, Fujisawa M. Urol Oncol; 2013 Nov 04; 31(8):1511-6. PubMed ID: 22658882 [Abstract] [Full Text] [Related]
17. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy. Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T. Clin Genitourin Cancer; 2018 Aug 04; 16(4):e817-e829. PubMed ID: 29576444 [Abstract] [Full Text] [Related]
18. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer. Preisser F, Würnschimmel C, Pose RM, Heinze A, Steuber T, Michl U, Salomon G, Mandel P, Graefen M, Tilki D. Prostate; 2022 Feb 04; 82(2):254-259. PubMed ID: 34807461 [Abstract] [Full Text] [Related]
19. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy. Keefe DT, Schieda N, El Hallani S, Breau RH, Morash C, Robertson SJ, Mai KT, Belanger EC, Flood TA. Virchows Arch; 2015 Oct 04; 467(4):437-42. PubMed ID: 26229020 [Abstract] [Full Text] [Related]
20. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter? Jin BS, Kang SH, Kim DY, Oh HG, Kim CI, Moon GH, Kwon TG, Park JS. Korean J Urol; 2015 Sep 04; 56(9):624-9. PubMed ID: 26366274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]